Motohiro Okada

Hirosaki University
Country flagJapan

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (39)

Year:

2026

In Japan, national crude suicide mortality rates (CMR-suicides) consistently decreased during the 2010s, whereas adolescent CMR-suicides have increased from the mid-2010s. However, the high-risk groups and their causalities remain to be clarified. Temporal fluctuations of adolescent CMR-suicides disaggregated by gender, age, social standing, and suicide motive were analyzed with joinpoint regression and linear mixed-effect models using two government suicide databases. CMR-suicides among female elementary school students, middle school students, high school students, university students, and <20-year-old individuals with social withdrawal syndrome (SWS) increased from the mid-2010s. CMR-suicides among male elementary school, middle school, and high school students also increased from the mid-2010s, while those of university students were unchanged. In contrast, CMR-suicides of males aged <20 and 20–29 with SWS unexpectedly decreased. Surprisingly, the increasing trends of CMR-suicides of female students were greater than males; consequently, CMR-suicides of female students in middle school and high school became greater than those of male students in the 2020s. The highest suicide risk among those under 20 years of age was observed among part-time high school students. Among individuals 20–29 years of age, those with SWS were in the highest-risk group for suicide, while CMR-suicides of individuals with SWS aged under 20 years were almost equivalent to those of middle school students. The leading suicide motives for elementary school students were family-related, including family discord and parental reprimand (there was no difference in gender in terms of leading suicide motive). Among middle school female students and older, the leading suicide motives were mental issues followed by school-related problems. Among male middle school students and older, the leading suicide motives were underachievement followed by mental issues. CMR-suicides caused by mental issues (for both genders) and underachievement (in males) increased from the mid-2010s. These results suggest that increasing internalizing problems may be a fundamental factor contributing to the currently increasing suicides among adolescents (particularly females) in Japan. Although the recent promotion of inclusive education in Japan has successfully provided educational opportunities for individuals with internalizing problems, these statistics highlight the need for a further enhancement of psychosocial support for adolescents with internalizing problems who are at a high risk for suicide.

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Background and Purpose d ‐cycloserine, N ‐methyl‐ d ‐aspartate/glutamate (NMDA) receptor co‐agonist (GluN2A/GluN2B partial and GluN2C super‐agonist), improves negative symptom of schizophrenia with narrow therapeutic window, but the mechanisms remains unclear. Experimental Approach Effects of chronic d ‐cycloserine administration (2–5 mg·kg −1 ) on sucrose preference of adult male rats were determined. Dose/concentration‐dependent effects of acute/chronic administrations of d ‐cycloserine (25–300 μM and 2–25 mg·kg −1 ) on expression of GluN2 subunits and associated transmission of l ‐glutamate/ d ‐serine/GABA were determined using microdialysis in adult male rats, primary cultured astrocytes (male/female neonatal rats) and capillary immunoblotting. Key Results d ‐cycloserine dose‐dependently increased release of astroglial l ‐glutamate/ d ‐serine and neuronal GABA in the thalamus and medial prefrontal cortex (mPFC) ( d ‐serine > GABA > l ‐glutamate), according to intrinsic activities (GluN2C > GluN2A [but unaffected GluN2B]). Chronic d ‐cycloserine dose‐dependently down‐regulated GluN2C > GluN2B > GluN2A (according to affinity) and attenuated d ‐cycloserine‐induced astroglial release of l ‐glutamate/ d ‐serine, dose dependently (GluN2C > GluN2A). Chronic exposure (25 μM) d ‐cycloserine down‐regulated GluN2C but increased GluN2C‐related astroglial l ‐glutamate/ d ‐serine release. Chronic exposure to >60μM d ‐cycloserine diminished GluN2C‐related astroglial release but activated GluN2A‐related release. Chronic administration of 2 but not 5‐mg·kg −1 d ‐cycloserine restored MK‐801‐induced decrease sucrose preference. Conclusion and Implications Chronic d ‐cycloserine (25 μM and 2 mg·kg −1 ) down‐regulated GluN2C without affecting GluN2A/GluN2B but increased GluN2‐related astroglial l ‐glutamate/ d ‐serine release. Higher d ‐cycloserine dose (>60 μM; >5 mg·kg −1 ) inactivated GluN2C, but increased GluN2A related astroglial release. These results indicate that dose‐dependent activation and inactivation of GluN2C by d ‐cycloserine is possibly involved in its efficacy on negative symptom of schizophrenia, but with a narrow therapeutic window.

Year:

2026

Background/Objectives: Deficits in auditory change detection are well-known in psychiatric disorders such as schizophrenia. An abrupt change in sound feature during periodic sounds elicits both evoked potentials and a transient change in neural oscillations. Both of these cerebral responses are thought to reflect the automatic change detection. However, the similarities and dissimilarities between these cerebral responses are unclear. To clarify them, we compared the temporal dynamics of evoked potentials and low gamma oscillations under a paired-pulse paradigm. Methods: Healthy adults (n = 21) participated. The stimulus was a 2 s sound consisting of a train of 25 ms pure tones. The sound pressure was increased by 15 dB twice within a 600 ms interval. Electroencephalographic signals were recorded from Fz and Cz electrodes referenced to linked mastoids. The peak (N100)-to-peak (P200) amplitude and the inter-trial phase coherence (ITPC) of low gamma oscillations were analyzed. Results: Auditory steady-state responses were evoked around 40 Hz. An abrupt change in sound pressure transiently decreased the ITPC of the oscillations at 40 Hz, whereas it increased the ITPC at the remaining frequencies. Unlike the change-related potentials, the degree of ITPC responses did not differ between the two changes. Conclusions: The synchrony of low gamma oscillations transiently responded to an abrupt increase in sound pressure but did not show paired-pulse suppression. This novel neurophysiological approach enables a focus on the neural change detection from multiple angles, which could be useful for investigations of psychiatric disorders.

Year:

2026

Aim The concomitant use of lamotrigine and valproic acid, a uridine diphosphate (UDP)‐glucuronosyltransferase inhibitor, is a known risk factor for lamotrigine‐induced rashes, which may develop into fatal or severe cutaneous adverse reactions. No drugs other than valproic acid have been shown to increase lamotrigine concentrations in humans by inhibiting UDP‐glucuronosyltransferase. The treatment of bipolar disorder and epilepsy is often combined with other medications, which may affect the risk of rash. We aimed to identify medications that increased the risk of lamotrigine‐induced rashes using clinical data. Methods We used VigiBase to search for drugs associated with the increased number of reported severe cutaneous adverse reactions when combined with lamotrigine. In a retrospective study, we collected information on patients from electronic medical records and used propensity score matching to compare the incidence of lamotrigine‐induced rash with and without flunitrazepam use. Furthermore, we compared lamotrigine concentrations between patients treated with and without flunitrazepam in a prospective observational study. Results VigiBase analysis showed that flunitrazepam significantly increased the reporting odds ratio for lamotrigine‐related severe cutaneous adverse reactions. In the retrospective study, combining lamotrigine with flunitrazepam significantly increased the incidence of rashes. In the prospective observational study, lamotrigine with flunitrazepam significantly increased the concentration‐to‐dose ratio. Conclusion Flunitrazepam use may affect lamotrigine concentration and increase the risk of rash. These results have implications for the choice of sleep medication. In addition, when lamotrigine is used in combination with flunitrazepam, the lamotrigine dosing design should address lamotrigine‐induced rash management.

Year:

2025

Objectives: We examined whether sensory inhibition was altered in patients with autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD) as deficits in the neural inhibition are considered to be involved in both disorders. Methods: By using auditory change-related brain potentials as the test response, paired pulse suppression (PPS) and prepulse inhibition (PPI) were compared among healthy controls (n = 57), patients with ASD (n = 22), and ADHD (n = 8). The test change-related response was elicited by an abrupt sound pressure increase in a continuous sound. In the PPS experiment, two 15 dB change stimuli were given 600 ms apart to elicit two change-related responses. In the PPI experiment, the test stimulus of a 10 dB increase and prepulse of a 2 dB increase were given with an interval of 50 ms. Evoked potentials were recorded from Cz referenced to the linked mastoids. Results: PPS differed significantly among the three groups, with a significantly lower value for ADHD than controls. PPI was significantly lower for ASD and ADHD than normal controls. Conclusions: Since these two measures are thought to represent changes in circuit excitability due to preceding stimuli via GABAergic transmission, the present results support the idea that dysfunction of the GABAergic system contributes to the etiology of these disorders. The present results showed that the pattern of dysfunction differed between the two disorders and suggest that measurements of inhibitory function may be able to differentiate between the two disorders.

Year:

2025

One of the challenges in diagnosing psychiatric disorders is that the results of biological and neuroscience research are not reflected in the diagnostic criteria. Thus, data‐driven analyses incorporating biological and cross‐disease perspectives, regardless of the diagnostic category, have recently been proposed. A data‐driven clustering study based on subcortical volumes in 5604 subjects classified into four brain biotypes associated with cognitive/social functioning. Among the four brain biotypes identified in controls and patients with schizophrenia, bipolar disorder, major depressive disorder, autism spectrum disorder, and other psychiatric disorders, we further analyzed the brain biotype 1 subjects, those with an extremely small limbic region, for clinical utility. We found that the representative feature of brain biotype 1 is enlarged lateral ventricles. An enlarged ventricle, defined by an average z ‐score of left and right lateral ventricle volumes > 3, had a sensitivity of 99.1% and a specificity of 98.1% for discriminating brain biotype 1. However, the presence of an enlarged ventricle was not sufficient to classify patient subgroups, as 1% of the controls also had enlarged ventricles. Reclassification of patients with enlarged ventricles according to cognitive impairment resulted in a stratified subgroup that included patients with a high proportion of schizophrenia diagnoses, electroencephalography abnormalities, and rare pathological genetic copy number variations. Data‐driven clustering analysis of neuroimaging data revealed subgroups with enlarged ventricles and cognitive impairment. This subgroup could be a new diagnostic candidate for psychiatric disorders. This concept and strategy may be useful for identifying biologically defined psychiatric disorders in the future.

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Collaborators (16)

Hisashi Narita

assistant professor

Hokkaido University Hospital

JAPAN
View details

Koji Inui

Institut de Recherche pour le Développement

JAPAN
View details

Keita Hirai

Professor

Wakayama Medical University

JAPAN
View details

Takahiro Niimura

Tokushima University Hospital

JAPAN
View details

Masaki Fukunaga

特任教授/Project Professor

生理学研究所/National Institute for Physiological Sciences

JAPAN
View details

Kouji Fukuyama

Mie university

JAPAN
View details

Kaoru Dohi

Mie University Graduate School of Medicine

JAPAN
View details

Manabu Kubota

Kyoto University

JAPAN
View details

Jun-ichi Iga

Professor

Ehime University

JAPAN
View details

Eishi Motomura

Mie university

JAPAN
View details

Tomohiko Nakayama

Lecturer

Tokushima University

JAPAN
View details

Jun Miyata

Professor

Aichi Medical University

JAPAN
View details

Atsushi Tajima

Professor

Kanazawa University

JAPAN
View details

Ryusuke Matsumoto

Mie university

JAPAN
View details

Masahito Nakataki

Tokushima University

JAPAN
View details

Kazuaki Mawatari

Associate Professor

Tokushima University

JAPAN
View details